The abstract is read at the publisher; the summary is JClub's.
In a multicenter cohort of 819 pediatric allogeneic hematopoietic cell transplant recipients, proven or probable human adenovirus disease occurred in 10.9% overall and 12.6% under surveillance.
- Why it matters: Limited surveillance-era data leave uncertainty about how often adenovirus infection progresses to disease and how often it results in death in pediatric allo-HCT patients.
- What they did: Researchers followed children for 180 days post-transplant at 10 institutions, using pre-HCT serum HAdV immunoglobulin G and stool HAdV PCR plus central committee review of PCR-informed outcomes.
- The result: Among those with proven or probable disease, the attributable case-fatality rate was 13.5%, and pre-HCT serology plus stool PCR positivity showed the highest infection incidence (52.0%).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.